TAUG — Tauriga Sciences Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Tauriga Sciences, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2017 March 31st	C2018 March 31st	2019 March 31st	C2020 March 31st	2021 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-2.27	-0.036	-1.1	-3.03	-3.63
Depreciation
Non-Cash Items	1.08	0.808	0.257	1.51	1.04
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0.531	-1.31	0.511	-0.043	0.08
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-0.651	-0.542	-0.329	-1.56	-2.5
Capital Expenditures	-0.001	-0.003	-0.012	-0.003	-0.016
Purchase of Fixed Assets
Other Investing Cash Flow Items	0	0.009	-0.056	-0.055	-0.404
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-0.001	0.006	-0.069	-0.058	-0.42
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0.652	0.549	0.771	1.24	2.97
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0	0.012	0.374	-0.381	0.044